CORRECTION article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1717357
Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker
Provisionally accepted
- 1Hubei Cancer Hospital, Wuhan, China
- 2Kindstar Global Precision Medicine Institute, WUHAN, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Authors Yiwei Zhou and Qijiao Li are employed by Kindstar Global Precision Medicine Institute. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. As an author of the aforementioned manuscript, I hereby solemnly declare: I have fully understood and agreed to the above author list correction, including the revised author order, equal contribution label, and affiliation information, with no objections; I confirm that Xiayu Wang and Yiwei Zhou undertook core work in "conceptualization, writing the original draft, and manuscript revision" during the research, which meets Frontiers' criteria for first authorship;This correction is a result of unanimous consultation among the author team, with no academic misconduct (e.g., unauthorized addition/removal of authors, falsification of contribution attribution), and complies with Frontiers' Authorship Policy and ICMJE Guidelines;Any academic disputes or controversies arising from this correction shall be borne by all authors, and the journal shall not be held liable.
Keywords: tcr, TILs, SMARCA4, lung cancer, Non-small cell lung carcinoma, Check-point inhibitors
Received: 01 Oct 2025; Accepted: 02 Oct 2025.
Copyright: © 2025 WANG, Zhou, Li, Qian, Wang and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
XIAYU WANG, wyx411910823@qq.com
Bing Yang, 245463239@qq.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.